Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00877474 · ClinicalTrials.gov registry record · Phase 1
Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors
A Phase 1 study, sponsored by PharmaMar.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00877474 is a Phase 1 study that has completed, run by PharmaMar. The registered enrollment target is 30 participants.
The verdict
NCT00877474, a Phase 1 study, has completed, sponsored by PharmaMar.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a phase I, multicenter, open-label, dose escalating clinical and pharmacokinetic study of PM01183 for patients with advanced solid tumors
Interventions
- DRUG PM01183
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00877474
The ClinicalTrials.gov registry entry for NCT00877474 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PharmaMar, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PM01183 is the first listed.
NCT00877474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00877474 about?
NCT00877474 is a clinical study titled "Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors". This is a phase I, multicenter, open-label, dose escalating clinical and pharmacokinetic study of PM01183 for patients with advanced solid tumors
What is the current status of trial NCT00877474?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2009-03. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00877474?
The interventions under investigation include: PM01183 (DRUG).
Who is sponsoring clinical trial NCT00877474?
This trial is sponsored by PharmaMar, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.